Zimbabwe has turned down a significant US healthcare agreement valued at $367m (272 million pounds) over five years because of the United States' demand for confidential information.
This rejection became public following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
An official spokesperson has since explained that the United States was seeking genetic material for scientific study and commercial gain while refused to share the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more dialogue to reach a deal agreeable to all parties so the nation's critical HIV treatment initiative can be sustained.
Wider Context
This development follows a similar case in neighbouring Kenya, where a high court halted a similar health funding agreement following legal challenges were raised about the safety of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance openness and responsibility.
As per statements, Sixteen African countries have to date agreed to similar agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment through US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its biological resources and data indefinitely, without any equivalent promise of benefiting from any medical innovations – like new medicines or tests – that could result from that shared data," his statement read.
"In essence, our nation would provide the basic resources for medical research with no certainty that the final treatments would be available to our population if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining structures already established through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to deal with potential pandemics.
"This mechanism is designed to ensure that when a country contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome further dialogue with our US partners on how future collaboration could be arranged in a way that honours the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that talks must proceed considering much of the country's Aids initiatives depended on external financing.
"In cases where specific concerns arise, including those involving data governance or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group commented.
This impasse underscores the complex tensions between receiving much-needed foreign assistance and safeguarding national sovereignty in an ever more data-driven world.